MOACM
PDLI

Mutual of America Capital Management’s PDL BioPharma, Inc. PDLI Stock Holding History

Mutual of America Capital Management’s Portfolio PDLI Stock Details PDLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-5,050
Closed -$39K – 1279
2014
Q4 		$39K Buy
5,050
+1,250
+33% +$9.89K ﹤0.01% 1199
2014
Q3 		$28K Sell
3,800
-3,000
-44% -$27.9K ﹤0.01% 1236
2014
Q2 		$66K Sell
6,800
-1,380
-17% -$12.3K ﹤0.01% 1157
2014
Q1 		$68K Buy
8,180
+2,000
+32% +$17.1K ﹤0.01% 1164
2013
Q4 		$52K Buy
+6,180
New +$52.1K ﹤0.01% 1193

Other funds holding PDLI

First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
AAM
Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GAM
Gotham Asset Management New York $32.7B AUM 27.65% 1-Year Est. Return

Mutual of America Capital Management's PDLI Position: Q1 2015 in Review

Mutual of America Capital Management sold out of PDL BioPharma, Inc. (PDLI) in Q1 2015, closing a stake of 5,050 shares — an estimated $39K sold.

Mutual of America Capital Management first reported a position in PDLI in Q4 2013 and held it in 5 quarters. The position peaked at $68K in Q1 2014. 215 funds tracked by Wall St. Rank hold PDLI as of Q1 2015.

  • Mutual of America Capital Management reported no remaining PDL BioPharma, Inc. position as of Q1 2015 after selling out during the quarter.
  • Mutual of America Capital Management sold 5,050 PDL BioPharma, Inc. shares in Q1 2015, an estimated $39K.
  • Mutual of America Capital Management first reported a position in PDL BioPharma, Inc. in Q4 2013 and held it in 5 quarters.
  • Mutual of America Capital Management's PDL BioPharma, Inc. position peaked at $68K in Q1 2014.
  • 215 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q1 2015.

Based on Mutual of America Capital Management's 13F filing for Q1 2015, filed 4 May 2015.